Hu QG - Search Results

1

[Research on the correlation of vascular endothelial growth factor and dendritic cell in patients with oral squamous cell carcinoma].

Shi PH, Hu QG, Wang ZY, Huang XF, Han W. Shi PH, et al. Among authors: hu qg. Zhonghua Kou Qiang Yi Xue Za Zhi. 2009 Mar;44(3):135-9. Zhonghua Kou Qiang Yi Xue Za Zhi. 2009. PMID: 19576015 Clinical Trial. Chinese.

2

[Effect of local immunotherapy of interleukin 2(IL-2) in combination with chemotherapy upon intratumoral lymphocytes in oral squamous cell carcinomas].

Tang E, Hu Q, Zhou B. Tang E, et al. Hua Xi Kou Qiang Yi Xue Za Zhi. 2003 Dec;21(6):444-6. Hua Xi Kou Qiang Yi Xue Za Zhi. 2003. PMID: 14732977 Clinical Trial. Chinese.

3

[Immunohistochemical analysis of dendritic cell in oral squamous cell carcinoma].

Wang ZY, Li SW, Hu QG, Tian WD. Wang ZY, et al. Among authors: hu qg. Hua Xi Kou Qiang Yi Xue Za Zhi. 2004 Apr;22(2):103-5, 131. Hua Xi Kou Qiang Yi Xue Za Zhi. 2004. PMID: 15190787 Chinese.

4

Enhanced therapeutic effect by combination of tumor-targeting Salmonella and endostatin in murine melanoma model.

Jia LJ, Xu HM, Ma DY, Hu QG, Huang XF, Jiang WH, Li SF, Jia KZ, Huang QL, Hua ZC. Jia LJ, et al. Among authors: hu qg. Cancer Biol Ther. 2005 Aug;4(8):840-5. doi: 10.4161/cbt.4.8.1891. Cancer Biol Ther. 2005. PMID: 16210914 Free article.

5

[Inhibitory effect of dendritic cell vaccine on the growth of implanted tongue squamous cell carcinoma tumors in nude mice].

Han W, Hu QG, Wang ZY. Han W, et al. Among authors: hu qg. Zhonghua Kou Qiang Yi Xue Za Zhi. 2006 Feb;41(2):81-4. Zhonghua Kou Qiang Yi Xue Za Zhi. 2006. PMID: 16640929 Chinese.

6

Polyethylenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics.

Li S, Dong W, Zong Y, Yin W, Jin G, Hu Q, Huang X, Jiang W, Hua ZC. Li S, et al. Mol Ther. 2007 Mar;15(3):515-23. doi: 10.1038/sj.mt.6300072. Epub 2007 Feb 6. Mol Ther. 2007. PMID: 17285141 Free article.

7

A monoclonal-antibody-based ELISA for the detection of human FADD (Fas-associated death domain).

Ye J, Shao H, Ma D, Qin A, Han B, Marikar FM, Cheng W, Huang X, Qiu Y, Hu Q, Hua Z. Ye J, et al. Biotechnol Appl Biochem. 2008 Jul;50(Pt 3):143-6. doi: 10.1042/BA20070217. Biotechnol Appl Biochem. 2008. PMID: 18167119

8

Metastases to lingual lymph nodes from squamous cell carcinoma of the tongue.

Han W, Yang X, Huang X, Hu Q, Wang Z. Han W, et al. Br J Oral Maxillofac Surg. 2008 Jul;46(5):376-8. doi: 10.1016/j.bjoms.2007.12.002. Epub 2008 Jan 18. Br J Oral Maxillofac Surg. 2008. PMID: 18207615

9

[Construction of targeting-Skp2 shRNA plasmids and observation of their inhibitory effect on Tca8113 cells].

Fang L, Hu QG, Hua ZC, Li SF. Fang L, et al. Among authors: hu qg. Zhonghua Kou Qiang Yi Xue Za Zhi. 2007 Oct;42(10):624-8. Zhonghua Kou Qiang Yi Xue Za Zhi. 2007. PMID: 18215375 Chinese.

10

A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.

Sun Q, Xu Q, Dong X, Cao L, Huang X, Hu Q, Hua ZC. Sun Q, et al. Int J Cancer. 2008 Aug 15;123(4):942-50. doi: 10.1002/ijc.23537. Int J Cancer. 2008. PMID: 18528863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters